Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Ifosfamide in Cisplatin-Failed Advanced Transitional Cell Carcinoma
NCT00173862Phase 2Completed
- Sponsor
- National Taiwan University Hospital
- Start
- May 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gemcitabine and ifosfamide in transitional cell carcinoma (TCC), sponsored by National Taiwan University Hospital. Primary endpoint: Response Rate. Started May 2000; status: completed.
02
Drugs
gemcitabineifosfamide
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on NCT00173862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00173862.